[PDF][PDF] Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer

R Timmerman, R McGarry, C Yiannoutsos… - Journal of clinical …, 2006 - academia.edu
Purpose Surgical resection is standard therapy in stage I non–small-cell lung cancer (NSCLC);
however, many patients are inoperable due to comorbid diseases. Building on a …

Stereotactic body radiation therapy for early-stage non–small-cell lung carcinoma: four-year results of a prospective phase II study

AJ Fakiris, RC McGarry, CT Yiannoutsos… - International Journal of …, 2009 - Elsevier
PURPOSE: The 50-month results of a prospective Phase II trial of stereotactic body radiation
therapy (SBRT) in medically inoperable patients are reported. METHODS AND MATERIALS…

Ordered multiple‐class ROC analysis with continuous measurements

CT Nakas, CT Yiannoutsos - Statistics in medicine, 2004 - Wiley Online Library
Receiver operating characteristic (ROC) curves have been useful in two‐group classification
problems. In three‐ and multiple‐class diagnostic problems, an ROC surface or hyper‐…

Pancreaticoduodenectomy: a 20-year experience in 516 patients

CM Schmidt, ES Powell, CT Yiannoutsos… - Archives of …, 2004 - jamanetwork.com
Hypothesis Pancreaticoduodenectomy (PD) is a safe procedure for a variety of periampullary
conditions. Design Retrospective review of a prospectively collected database. Setting …

Phase III study of cisplatin, etoposide, and concurrent chest radiation with or without consolidation docetaxel in patients with inoperable stage III non–small-cell lung …

N Hanna, M Neubauer, C Yiannoutsos… - Journal of clinical …, 2008 - ascopubs.org
Purpose Concurrent chemoradiotherapy is standard treatment for patients with inoperable
stage III non–small-cell lung cancer (NSCLC). A phase II study by the Southwest Oncology …

Intraductal papillary mucinous neoplasms: predictors of malignant and invasive pathology

…, PB White, JA Waters, CT Yiannoutsos… - Annals of …, 2007 - journals.lww.com
Objective: Determine whether size and other preoperative parameters predict malignant or
invasive intraductal papillary mucinous neoplasia (IPMN). Summary Background Data: From …

Retention in care among HIV-infected patients in resource-limited settings: emerging insights and new directions

…, W Muyindike, MB Bwana, CT Yiannoutsos… - Current Hiv/aids …, 2010 - Springer
In resource-limited settings—where a massive scale up of HIV services has occurred in the
last 5 years—both understanding the extent of and improving retention in care presents …

Understanding reasons for and outcomes of patients lost to follow-up in antiretroviral therapy programs in Africa through a sampling-based approach

…, MB Bwana, CT Yiannoutsos… - JAIDS Journal of …, 2010 - journals.lww.com
Objectives: Losses to follow-up after initiation of antiretroviral therapy (ART) are common in
Africa and are a considerable obstacle to understanding the effectiveness of nascent …

Persistence of HIV-associated cognitive impairment, inflammation, and neuronal injury in era of highly active antiretroviral treatment

…, E Daar, J Alger, E Singer, T Campbell, C Yiannoutsos… - Aids, 2011 - journals.lww.com
Objective: To determine whether cognitive impairment and brain injury as measured by
proton magnetic resonance spectroscopy (MRS) persist in the setting of HAART. Design: This …

Viability and effectiveness of large-scale HIV treatment initiatives in sub-Saharan Africa: experience from western Kenya

…, S Kimaiyo, L Diero, A Siika, J Sidle, CT Yiannoutsos… - Aids, 2006 - journals.lww.com
Objectives: To determine the clinical and immunological outcomes of a cohort of HIV-infected
patients receiving antiretroviral therapy. Design: Retrospective study of prospectively …